Schedule 13G ownership disclosure

Avidity Biosciences Inc

COMMON STOCK · CUSIP: 05370A108

Event date: 2025-09-30

Filing-level shares
9,787,912
Percent of class
7.1%
  • T. Rowe Price Associates, Inc.

    Shares: 9,787,912 · Class: 7.1%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000080255-25-000834
Form type
SCHEDULE 13G/A
Filer
Avidity Biosciences, Inc.
CIK
CIK 1599901
Filed
Nov 14, 2025
Reporting period
Sep 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub